Q517--FY26: VISN 8 Pharmacy Emergent First Fill Prescription Services

248-Network Contract Office 8 (36C248) · United States government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

December 30, 2026
Response Due
Active
Status

Opportunity Overview

This amendment is to correct the due date for quotes on the SF1449.  changed from 12/02/2025 to 12/18/2025.

VISN 8 is anticipating a  Firm Fixed Indefinite Delivery Indefinite Quantity contract for VISN 8 EMERGENT PHARMACY FIRST FILL PRESCRIPTION SERVICES Base plus Four Option Years at the following VISN 8 VA Medical Centers and their outlying CBOCs, and CMBOCs. Locations are listed below.

Bay Pines, Tampa, Orlando, North Florida/South Georgia, Miami, West Palm Beach, San Juan PR, and the Clinical Contact Center, Tampa FL.

See PWS for futher information.

Quotes are due NLT 10:00AM EST; December 30, 2025.

This is one of 54 active United States Medical Equipment opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agency248-Network Contract Office 8 (36C248)
CountryUnited States
CategoryMedical Equipment
NAICS524292
PSCQ517
PublishedDecember 02, 2025
Procurement stageRequest for Proposal (RFP)
Response dueDecember 30, 2026
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Related Opportunities in United States

Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Acute Hemodialysis Treatments and Equipment Maintenance
Second Chance Act Goods and Services
RFP-797-Fss-04-0001-R3: 621ii Medical Laboratory Testing & Analysis Services
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

See every United States Medical Equipment opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Medical Equipment intelligence report in your inbox

A personalized report on United States Medical Equipment opportunities, emailed in 5-10 minutes. One per month, no account needed.